Torno Capital, LLC Bei Gene, Ltd. Call Options Transaction History

Torno Capital, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$129.52 - $174.32 $401,512 - $540,392	3,100 Added 44.93%	10,000 $1.43 Billion
Q1 2024 May 15, 2024	SELL	$141.8 - $181.47 $439,580 - $562,557	-3,100 Reduced 31.0%	6,900 $1.08 Billion
Q4 2023 Feb 14, 2024	BUY	$158.67 - $201.58 $1.59 Million - $2.02 Million	10,000 New	10,000 $1.8 Billion

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Torno Capital, LLC with notifications on news.